Vivek Narayan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 21
- Renal cell carcinoma treatment 16
- Oncology 32
- Cancer Immunotherapy and Biomarkers 10
- CAR-T cell therapy research 8
- PARP inhibition in cancer therapy 8
- Co-authors
- Bonnie Ky (17 shared papers)Naomi B. Haas (20 shared papers)David J. Vaughn (11 shared papers)Russell K. Pachynski (4 shared papers)Aude Fléchon (2 shared papers)Sumit K. Subudhi (2 shared papers)Akash Patnaik (2 shared papers)Hakim Mahammedi (2 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Clinical Genitourinary Cancer (6 papers)Annals of Oncology (4 papers)Journal of the American College of Cardiology (3 papers)Cancer (3 papers)
- Partner nations
- United StatesFranceDenmark
In The Last Decade
Vivek Narayan
92 papers receiving 1.8k citations
Vivek Narayan's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 680
- Pulmonary and Respiratory Medicine 726
- Cancer Research 251
- Cardiology and Cardiovascular Medicine 308
- Immunology 222
Countries citing papers authored by Vivek Narayan
This map shows the geographic impact of Vivek Narayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Narayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Narayan more than expected).
Fields of papers citing papers by Vivek Narayan
This network shows the impact of papers produced by Vivek Narayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Narayan. The network helps show where Vivek Narayan may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivek Narayan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 270 | |
| 2 | A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 176 |
| 3 | 2020 | 94 | |
| 4 | 2022 | 93 | |
| 5 | 2017 | 89 | |
| 6 | 2019 | 71 | |
| 7 | 2020 | 61 | |
| 8 | 2017 | 59 | |
| 9 | 2018 | 56 | |
| 10 | 2021 | 56 | |
| 11 | 2021 | 49 | |
| 12 | 2012 | 36 | |
| 13 | 2018 | 35 | |
| 14 | 2016 | 35 | |
| 15 | 2020 | 33 | |
| 16 | 2018 | 33 | |
| 17 | 2019 | 32 | |
| 18 | 2016 | 26 | |
| 19 | 2022 | 26 | |
| 20 | 2019 | 25 |
About Vivek Narayan
Vivek Narayan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Cardiology and Cardiovascular Medicine and Molecular Biology, having authored 100 papers that have together received 1.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (21 papers), Renal cell carcinoma treatment (16 papers), Cancer, Hypoxia, and Metabolism (14 papers), Chemotherapy-induced cardiotoxicity and mitigation (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), CAR-T cell therapy research (8 papers), PARP inhibition in cancer therapy (8 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Oncology (680 citations), Pulmonary and Respiratory Medicine (726 citations), Cancer Research (251 citations), Cardiology and Cardiovascular Medicine (308 citations) and Immunology (222 citations). Vivek Narayan has collaborated with scholars based in United States, France and Denmark. Frequent co-authors include Bonnie Ky, Naomi B. Haas, David J. Vaughn, Russell K. Pachynski, Aude Fléchon, Sumit K. Subudhi, Akash Patnaik, Hakim Mahammedi, Gwénaëlle Gravis and G. Celine Han. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Annals of Oncology, Journal of the American College of Cardiology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.